▲ Peaking
Business
Biogen Alzheimer's drug slowed decline at rates on par with approved therapies, study shows
2sources
2articles
1velocity
-43%since first seen
36m agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (2)
- Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s? Barron's · 5h ago
- An experimental Alzheimer's drug shows some promise as researchers hunt new approaches ABC News - Breaking News, Latest News and Videos · 5h ago
Related trends
▲ Peaking
Business
United Airlines is replacing some of its middle seats with this new amenity - WGN-TV
▲ Peaking
Business
New Social Security COLA projections released for 2027 adjustment
▲ Peaking
Business
Billionaire Warren Buffett stops donations to Bill Gates charity
▲ Peaking
Business
US stocks hold steadier after inflation data, even as IBM plunges
▲ Peaking
Business
TSMC Sales Jump 36% as Memory Stocks Plunge. What It Means for NVIDIA and AMD
▲ Peaking
Business